Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This is a one-day, randomized, double-masked, single-center evaluation of the efficacy and
safety of PRX-100 ophthalmic solution compared to placebo in 20 subjects (randomized 4:1,
PRX-100:placebo) to evaluate the safety of PRX-100 and the magnitude and duration of effects
on improving near-vision acuity.